第一单位：
Laboratory of Molecular Target Therapy, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Yamasaki 2641, Noda, Chiba, 278-8510, Japan; Department of Biochemistry and Cell Biology, National Institute of Infectious Diseases, 1-23-1, Toyama, Shinjuku-ku, Tokyo, 162-8640, Japan.
作者：
Mana,Murae [1]
;
Yoshimi,Shimizu [2]
;
Yuichiro,Yamamoto [3]
;
Asuka,Kobayashi [3]
;
Masumi,Houri [3]
;
Tetsuya,Inoue [3]
;
Takuya,Irie [1]
;
Ryutaro,Gemba [4]
;
Yosuke,Kondo [5]
;
Yoshio,Nakano [5]
;
Satoru,Miyazaki [5]
;
Daisuke,Yamada [6]
;
Akiyoshi,Saitoh [6]
;
Isao,Ishii [7]
;
Taishi,Onodera [8]
;
Yoshimasa,Takahashi [8]
;
Takaji,Wakita [9]
;
Masayoshi,Fukasawa [10]
;
Kohji,Noguchi [11]
作者单位：
Laboratory of Molecular Target Therapy, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Yamasaki 2641, Noda, Chiba, 278-8510, Japan; Department of Biochemistry and Cell Biology, National Institute of Infectious Diseases, 1-23-1, Toyama, Shinjuku-ku, Tokyo, 162-8640, Japan.
[1]
Department of Biochemistry and Cell Biology, National Institute of Infectious Diseases, 1-23-1, Toyama, Shinjuku-ku, Tokyo, 162-8640, Japan; Department of Pharmaceutical Sciences, Teikyo Heisei University, 4-21-2 Nakano, Nakano-ku, 164-8530, Japan.
[2]
Laboratory of Molecular Target Therapy, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Yamasaki 2641, Noda, Chiba, 278-8510, Japan.
[3]
Department of Biochemistry and Cell Biology, National Institute of Infectious Diseases, 1-23-1, Toyama, Shinjuku-ku, Tokyo, 162-8640, Japan.
[4]
Department of Medical and Life Science, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Yamasaki 2641, Noda, Chiba, 278-8510, Japan.
[5]
Laboratory of Pharmacology, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Yamasaki 2641, Noda, Chiba, 278-8510, Japan.
[6]
Department of Health Chemistry, Showa Pharmaceutical University, Tokyo, 194-8543, Japan.
[7]
Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, 1-23-1, Toyama, Shinjuku-ku, Tokyo, 162-8640, Japan.
[8]
National Institute of Infectious Diseases, 1-23-1, Toyama, Shinjuku-ku, Tokyo, 162-8640, Japan.
[9]
Laboratory of Molecular Target Therapy, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Yamasaki 2641, Noda, Chiba, 278-8510, Japan; Department of Biochemistry and Cell Biology, National Institute of Infectious Diseases, 1-23-1, Toyama, Shinjuku-ku, Tokyo, 162-8640, Japan. Electronic address: fuka@nih.go.jp.
[10]
Laboratory of Molecular Target Therapy, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Yamasaki 2641, Noda, Chiba, 278-8510, Japan; Department of Biochemistry and Cell Biology, National Institute of Infectious Diseases, 1-23-1, Toyama, Shinjuku-ku, Tokyo, 162-8640, Japan. Electronic address: noguchi-kj@rs.tus.ac.jp.
[11]
DOI
10.1016/j.bbrc.2022.01.106
PMID
35123263
发布时间
2023-10-16
换一批
换一批
